Talk:Dextrorphan
This page has not been fully approved by the PsychonautWiki administrators. It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards. |
Summary sheet: Dextrorphan |
Dextrorphan | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||
Common names | DXO | ||||||||||||||||||||
Substitutive name | Dextrorphan | ||||||||||||||||||||
Systematic name | (+)-17-methyl-9a,13a,14a-morphinan-3-ol | ||||||||||||||||||||
Class Membership | |||||||||||||||||||||
Psychoactive class | Dissociative | ||||||||||||||||||||
Chemical class | Morphinan | ||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||
|
|||||||||||||||||||||
Interactions | |||||||||||||||||||||
Benzodiazepines | |||||||||||||||||||||
Cannabis | |||||||||||||||||||||
DOx | |||||||||||||||||||||
25x-NBOMe | |||||||||||||||||||||
2C-T-x | |||||||||||||||||||||
5-MeO-xxT | |||||||||||||||||||||
Amphetamines | |||||||||||||||||||||
Cocaine | |||||||||||||||||||||
Bupropion | |||||||||||||||||||||
ΑMT | |||||||||||||||||||||
PCP | |||||||||||||||||||||
MDMA | |||||||||||||||||||||
Alcohol | |||||||||||||||||||||
GHB | |||||||||||||||||||||
GBL | |||||||||||||||||||||
Opioids | |||||||||||||||||||||
Tramadol | |||||||||||||||||||||
MAOIs | |||||||||||||||||||||
SSRIs | |||||||||||||||||||||
Antihistamines |
Dextrorphan (also known as DXO) is a dissociative drug of the morphinan class. It's the main active metabolite of dextromethorphan (DXM). It appears as a colorless powder.[1]
Chemistry
Dextrorphan is a dextrorotatory molecule of the morphinan class. It contains a phenanthrene core structure with one aromatic ring (benzene) bound to two saturated rings (cyclohexane). Dextromethorphan is metabolized in the body by o-demethylation through the CYP2D6 enzyme to form Dextrorphan.[2]
Pharmacology
The pharmacology of dextrorphan is similar to that of dextromethorphan (DXM). However, dextrorphan is much more potent as an NMDA receptor antagonist as well as essentially inactive as a serotonin reuptake inhibitor.[3] DXO is an active chemical and contributes to the subjective effects experienced when active doses of DXM are consumed.[4]
Binding affinities (Ki)
- NMDA antagonist - 486 nM
- Sigma-1 agonist - 351 nM
- Serotonin transporter (SERT) - 484 nM
- Mu opioid agonist - 420 nM
Subjective effects
Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.
It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.
One user reported excessive itchiness accompanied by a "peaceful yet emotionless state" after 340mg of the substance was consumed.[5]
Physical effects
-
- Appetite suppression
- Changes in felt bodily form
- Gustatory hallucinations
- Itchiness - This effect has become subsequently known as "robo-itch" and though relatively common there are many users who never experience this particular effect while some individuals can experience it quite intensely.
- Muscle spasms
- Motor control loss
- Pain relief
- Perception of decreased weight
- Physical autonomy
- Spatial disorientation
- Tactile disconnection
- Tactile suppression
Cognitive effects
-
- Amnesia
- Conceptual thinking
- Consciousness disconnection
- Creativity enhancement
- Déjà vu
- Depersonalization
- Derealization
- Disinhibition
- Existential self-realization
- Immersion enhancement
- Increased music appreciation
- Information processing suppression
- Memory suppression
- Novelty enhancement
- Personal bias suppression
- Thought deceleration
- Time distortion
- Unity and interconnectedness
Experience reports
There are currently 0 experience reports which describe the effects of this substance in our experience index.
Additional experience reports can be found here:
Toxicity and harm potential
This toxicity and harm potential section is a stub. As a result, it may contain incomplete or even dangerously wrong information! You can help by expanding upon or correcting it. |
It is strongly recommended that one use harm reduction practices when using this substance.
Lethal dosage
Tolerance and addiction potential
Dangerous interactions
This dangerous interactions section is a stub. As such, it may contain incomplete or invalid information. You can help by expanding upon or correcting it. |
Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).
Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.
- Depressants (e.g. 2M2B, alcohol, barbiturates, benzodiazepines, GHB/GBL, methaqualone, opioids) - This combination potentiates the muscle relaxation, amnesia, sedation, and respiratory depression caused by one another and at higher doses, can lead to a sudden, unexpected loss of consciousness along with dangerously depressed respiration. There is also an increased risk of vomiting while unconsciousness and dying from the resulting suffocation. If nausea or vomiting occurs before consciousness is lost, users should attempt to fall asleep in the recovery position or have a friend move them into it.
- Stimulants (e.g. amphetamine, cocaine, methylphenidate, MDMA) - This combination can potentiate the anxiety-inducing, manic, delusional and disinhibiting effects of dissociatives, particularly those without pronounced motor suppressing components such as ketamine. The sum of these effects can increase the likelihood of an anxiety attack, delusions or a psychotic episode. There is also evidence that suggests that combining these two increases their neurotoxicity.[citation needed] Anecdotally, worsened comedowns are also commonly reported when these two classes of substances are combined.
- Dissociatives (e.g. dextromethorphan, ketamine, methoxetamine, PCP) - Combination can unpredictably potentiate amnesia, sedation, motor control loss and delusions. It may also result in a sudden loss of consciousness along with a dangerous amount of respiratory depression. If nausea or vomiting occurs before consciousness is lost, users should attempt to fall asleep in the recovery position or have a friend move them into it.
Legal issues
This legality section is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
- Germany: Dextrorphan is uncontrolled.[citation needed]
- Poland: Dextrorphan is unscheduled.[6]
- United States: Dextrorphan is unscheduled since October 1, 1976.[7]
See also
External links
References
- ↑ "Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml
- ↑ Cytochrome P450-dependent metabolism of dextromethorphan: fetal and adult studies. | https://www.ncbi.nlm.nih.gov/pubmed/1306804
- ↑ Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism: A Pilot Study | http://journals.lww.com/psychopharmacology/pages/articleviewer.aspx?year=1998&issue=08000&article=00014&type=abstract
- ↑ Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders - 3. Pharmacodynamics (January 2016) | https://www.researchgate.net/publication/292212463_Dextromethorphan_An_update_on_its_utility_for_neurological_and_neuropsychiatric_disorders
- ↑ "Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml
- ↑ List of scheduled substances in Poland. | http://www2.mz.gov.pl/wwwfiles/ma_struktura/docs/zal2_uopnarkomanii_29072005.pdf
- ↑ DEA: "Lists of: Scheduling Actions Controlled Substances Regulated Chemicals"